Advertisement
Screener

Siga Technologies INC (SIGA) Income (Loss) Attributable to Parent, before Tax

1.6 / 5 stars · 32/98 Roast Me

Siga Technologies INC Income (Loss) Attributable to Parent, before Tax

Siga Technologies INC (SIGA) reported Income (Loss) Attributable to Parent, before Tax of $14.90 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.

Financial Statements › Expense Statement › Operating Expenses

us-gaap:IncomeLossAttributableToParent · last filed 2026-08-06

  • Siga Technologies INC income (loss) attributable to parent, before tax for the quarter ending 2026-06-30 was $14.90M, a 68.50% decline year-over-year.
  • Siga Technologies INC income (loss) attributable to parent, before tax for the quarter ending 2026-03-31 was -$4.00M.
  • Siga Technologies INC income (loss) attributable to parent, before tax for the quarter ending 2025-09-30 was -$8.40M, a 542.11% decline year-over-year.
  • Siga Technologies INC income (loss) attributable to parent, before tax for the quarter ending 2025-06-30 was $47.30M, a 1870.83% increase year-over-year.
Period endIncome (Loss) Attributable to Parent, before Tax 3 monthIncome (Loss) Attributable to Parent, before Tax 3 month as first filedIncome (Loss) Attributable to Parent, before Tax 6 monthIncome (Loss) Attributable to Parent, before Tax 6 month as first filedIncome (Loss) Attributable to Parent, before Tax 9 monthIncome (Loss) Attributable to Parent, before Tax 9 month as first filed
2026-06-30$14.90M
10-Q · filed 2026-08-06
$10.80M
10-Q · filed 2026-08-06
2026-03-31-$4.00M
10-Q · filed 2026-05-07
2025-09-30-$8.40M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06
$38.90M
derived: sum of 2 quarters · filed 2026-08-06
$38.30M
10-Q · filed 2025-11-06
2025-06-30$47.30M
10-Q · filed 2026-08-06
$46.70M
10-Q · filed 2026-08-06
2025-03-31-$600.00K
10-Q · filed 2026-05-07
2024-09-30$1.90M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06
$4.30M
derived: sum of 2 quarters · filed 2025-11-06
$17.50M
10-Q · filed 2025-11-06
2024-06-30$2.40M
10-Q · filed 2025-08-05
$15.60M
10-Q · filed 2025-08-05
2024-03-31$13.20M
10-Q · filed 2025-05-08
2023-09-30-$400.00K
10-Q · filed 2023-11-07
-$3.80M
derived: sum of 2 quarters · filed 2024-08-01
-$5.10M
10-Q · filed 2024-11-07
2023-06-30-$3.40M
10-Q · filed 2024-08-01
-$4.70M
10-Q · filed 2024-08-01
2023-03-31-$1.20M
10-Q · filed 2024-05-07
2022-09-30$43.10M
10-Q · filed 2023-11-07
$46.30M
derived: sum of 2 quarters · filed 2023-11-07
$45.30M
10-Q · filed 2023-11-07
2022-06-30$3.20M
10-Q · filed 2023-08-08
$2.10M
10-Q · filed 2023-08-08
2022-03-31-$1.10M
10-Q · filed 2023-05-04
2021-09-30-$4.00M
10-Q · filed 2022-11-03
-$3.50M
derived: sum of 2 quarters · filed 2022-11-03
-$4.60M
10-Q · filed 2022-11-03
2021-06-30$500.00K
10-Q · filed 2022-08-04
$600.00K
10-Q · filed 2022-08-04
-$600.00K
10-Q · filed 2021-08-05
2021-03-31-$1.00M
10-Q · filed 2022-05-05
$1.00M
10-Q · filed 2021-05-06
2020-09-30$31.60M
10-Q · filed 2021-11-04
$58.80M
derived: sum of 2 quarters · filed 2021-11-04
$47.30M
10-Q · filed 2021-11-04
2020-06-30$27.20M
10-Q · filed 2021-08-05
$15.60M
10-Q · filed 2021-08-05
2020-03-31$11.60M
10-Q · filed 2021-05-06
-$11.60M
10-Q · filed 2020-05-06
2019-09-30-$1.60M
10-Q · filed 2020-11-05
-$5.90M
derived: sum of 2 quarters · filed 2020-11-05
-$3.70M
10-Q · filed 2020-11-05
2019-06-30-$4.30M
10-Q · filed 2020-08-06
-$2.10M
10-Q · filed 2020-08-06
2019-03-31$2.10M
10-Q · filed 2020-05-06
2018-09-30$362.64M
10-Q · filed 2019-11-05
$362.62M
10-Q · filed 2018-11-06
$355.55M
derived: sum of 2 quarters · filed 2019-11-05
$344.00M
10-Q · filed 2019-11-05
$343.99M
10-Q · filed 2018-11-06
2018-06-30-$7.09M
10-Q · filed 2018-08-07
-$18.67M
10-Q · filed 2018-08-07

Similar stocks

Stock NameCountryMarket CapPE Ratio
Sionna Therapeutics, Inc. (SION)United States$0.236B-20.37
Cartesian Therapeutics, Inc. (RNAC)United States$0.231B-2.04
Keros Therapeutics, Inc. (KROS)United States$0.229B-2.55
Camp4 Therapeutics Corp (CAMP)United States$0.240B-2.12
NATURES SUNSHINE PRODUCTS INC (NATR)United States$0.228B20.51
MACROGENICS INC (MGNX)United States$0.242B-20.11
Cue Biopharma, Inc. (CUE)United States$0.243B-1.01
Entrada Therapeutics, Inc. (TRDA)United States$0.243B-1.73
Pyxis Oncology, Inc. (PYXS)United States$0.244B
Whitehawk Therapeutics, Inc. (WHWK)United States$0.221B